435 related articles for article (PubMed ID: 30144562)
1. Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience.
Sartain S; Shubert S; Wu MF; Srivaths P; Teruya J; Krance R; Martinez C
Biol Blood Marrow Transplant; 2019 Jan; 25(1):157-162. PubMed ID: 30144562
[TBL] [Abstract][Full Text] [Related]
2. Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?
Jodele S; Laskin BL; Goebel J; Khoury JC; Pinkard SL; Carey PM; Davies SM
Transfusion; 2013 Mar; 53(3):661-7. PubMed ID: 22804695
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
Schoettler M; Lehmann L; Li A; Ma C; Duncan C
Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and outcomes of pediatric transplant-associated thrombotic microangiopathy in Hong Kong.
Chan WYK; Ma ALT; Chan EYH; Kan ANC; Ng WF; Lee PPW; Cheuk DKL; Chiang AKS; Leung W; Chan GCF
Pediatr Transplant; 2022 Nov; 26(7):e14366. PubMed ID: 35860972
[TBL] [Abstract][Full Text] [Related]
5. Severe transplant-associated thrombotic microangiopathy in patients with hemoglobinopathies.
Abusin GA; Abu-Arja R; Bajwa RPS; Horwitz EM; Auletta JJ; Rangarajan HG
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28333416
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort study.
Yang LP; Zhao P; Wu YJ; Fu HX; He Y; Mo XD; Lv M; Wang FR; Yan CH; Chen YH; Chang YJ; Xu LP; Liu KY; Huang XJ; Zhang XH
Bone Marrow Transplant; 2022 Apr; 57(4):554-561. PubMed ID: 35079139
[TBL] [Abstract][Full Text] [Related]
7. Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).
Benítez Carabante MI; Bueno D; Alonso García L; López Torija I; Marsal J; Fernandez Navarro JM; Uria Oficialdegui ML; Panesso M; Molina B; Beléndez Bieler C; Palomo P; Pérez Martínez A; Diaz-de-Heredia C
Transplant Cell Ther; 2024 Jun; 30(6):601.e1-601.e13. PubMed ID: 38521410
[TBL] [Abstract][Full Text] [Related]
8. [Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review].
Han W; Han Y; Chen J; Ma X; Chen F; Wu XJ; Qi JQ; Qiu HY; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):666-70. PubMed ID: 27587247
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options.
Kim SS; Patel M; Yum K; Keyzner A
Transfusion; 2015 Feb; 55(2):452-8. PubMed ID: 25209960
[TBL] [Abstract][Full Text] [Related]
10. The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy.
Sartain S; Shubert S; Wu MF; Wang T; Martinez C
Pediatr Blood Cancer; 2020 Mar; 67(3):e28070. PubMed ID: 31774252
[TBL] [Abstract][Full Text] [Related]
11. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
Jodele S; Dandoy CE; Myers KC; El-Bietar J; Nelson A; Wallace G; Laskin BL
Transfus Apher Sci; 2016 Apr; 54(2):181-90. PubMed ID: 27156964
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis.
Luo L; Xiong H; Chen Z; Yang L; Sun M; Lu W; Tao F; Wang Z; Li J; Li Z; Tang S
Clin Transl Oncol; 2023 Aug; 25(8):2451-2461. PubMed ID: 36973479
[TBL] [Abstract][Full Text] [Related]
13. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
[TBL] [Abstract][Full Text] [Related]
14. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
Jodele S; Laskin BL; Dandoy CE; Myers KC; El-Bietar J; Davies SM; Goebel J; Dixon BP
Blood Rev; 2015 May; 29(3):191-204. PubMed ID: 25483393
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic plasma exchange: single-center experience in children with kidney disorders.
Joseph C; Siddiqui S; Shah S; Solomon CH; Srivaths PR
Pediatr Nephrol; 2021 Mar; 36(3):621-629. PubMed ID: 32949283
[TBL] [Abstract][Full Text] [Related]
16. Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand.
Lazana I
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674666
[TBL] [Abstract][Full Text] [Related]
17. Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab.
Jodele S; Dandoy CE; Lane A; Laskin BL; Teusink-Cross A; Myers KC; Wallace G; Nelson A; Bleesing J; Chima RS; Hirsch R; Ryan TD; Benoit S; Mizuno K; Warren M; Davies SM
Blood; 2020 Mar; 135(13):1049-1057. PubMed ID: 31932840
[TBL] [Abstract][Full Text] [Related]
18. Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy.
Epperla N; Li A; Logan B; Fretham C; Chhabra S; Aljurf M; Chee L; Copelan E; Freytes CO; Hematti P; Lazarus HM; Litzow M; Nishihori T; Olsson RF; Prestidge T; Saber W; Wirk B; Yared JA; Loren A; Pasquini M
Br J Haematol; 2020 Jun; 189(6):1171-1181. PubMed ID: 32124435
[TBL] [Abstract][Full Text] [Related]
19. Comparison of multiple treatments in the management of transplant-related thrombotic microangiopathy: a network meta-analysis.
Yang J; Xu X; Han S; Qi J; Li X; Pan T; Zhang R; Han Y
Ann Hematol; 2023 Jan; 102(1):31-39. PubMed ID: 36547721
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic Microangiopathy Increases the Risk of Chronic Kidney Disease but Not Overall Mortality in Long-term Transplant Survivors.
Li A; Gupta R; Amos CI; Davis C; Pao E; Lee SJ; Hingorani SR
Transplant Cell Ther; 2021 Oct; 27(10):864.e1-864.e5. PubMed ID: 34217847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
